Researchers at Moffitt Cancer Center and the University of South Florida have found that men with prostate cancer who receive androgen deprivation therapy may predictably suffer from fatigue if they have single nucleotide polymorphisms in three pro-inflammatory genes. The discovery highlights the importance of personalized medicine, in which therapies are tailored to a patient's genetic profile. The study appears in the October issue of Brain, Behavior, and Immunity...
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment